Angiogenesis, stem cells, eNOS and inflammation – the many faces of vascular biology

• References

• 1 Pardali E, Waltenberger J. Monocyte function and trafficking in cardiovascular disease. Thromb Haemost 2012; 108: 804-811.
• 2 Sagan A, Mrowiecki W, Mikolajczyk T. et al. Local inflammation is associated with aortic thrombus formation in abdominal aortic aneurysms. Relationship to clinical risk factors. Thromb Haemost 2012; 108: 812-823.
• 3 Nowak WN, Mika P, Nowobilski R. et al. Exercise training in intermittent claudication: effects on antioxidant genes, inflammatory mediators, and proangiogenic progenitor cells. Thromb Haemost 2012; 108: 801-803.
• 4 McNeill E, Channon KM. The Role of Tetrahydrobiopterin in Inflammation and Cardiovascular Disease. Thromb Haemost 2012; 108: 832-839.
• 5 Antonopoulos AS, Margaritis M, Shirodaria C. et al. Translating the vascular effects of statins: from redox modulation to suppression of vascular wall inflammation. Thromb Haemost 2012; 108: 840-848.
• 6 Petry A, BelAiba RS, Weitnauer M. et al. Inhibition of endothelial NO synthase increases capillary formation via Rac1- dependent induction of HIF-1a and PAI-1. Thromb Haemost 2012; 108: 849-862.
• 7 Geenen ILA, Post MJ, Molin DGM. et al. Coagulation on Endothelial Cells; the Underexposed Part of Virchow’s Triad. Thromb Hemostasis. Thromb Haemost 2012; 108: 863-871.
• 8 Harrison DG, Guzik TJ, Goronzy J. et al. Is hypertension an immunologic disease?. Curr Cardiol Rep 2008; 10: 464-469.
• 9 Antoniades C, Shirodaria C, Van Assche T. et al. GCH1 haplotype determines vascular and plasma biopterin availability in coronary artery disease effects on vascular superoxide production and endothelial function. J Am Coll Cardiol 2008; 52: 158-165.
• 10 Okazaki T, Otani H, Shimazu T. et al. Reversal of inducible nitric oxide synthase uncoupling unmasks tolerance to ischemia/reperfusion injury in the diabetic rat heart. J Mol Cell Cardiol 2011; 50: 534-544.
• 11 Dulak J, Józkowicz A, Dembinska-Kiec A. et al. Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2000; 20: 659-666.
• 12 Jozkowicz A, Cooke JP, Guevara I. et al. Genetic augmentation of nitric oxide synthase increases the vascular generation of VEGF. Cardiovasc Res 2001; 51: 773-783.
• 13 Kane AJ, Barker JE, Mitchell GM. et al. Inducible nitric oxide synthase (iNOS) activity promotes ischaemic skin flap survival. Br J Pharmacol 2001; 132: 1631-1638.
• 14 Kisley LR, Barrett BS, Bauer AK. et al. Genetic ablation of inducible nitric oxide synthase decreases mouse lung tumorigenesis. Cancer Res 2002; 62: 6850-6856.
• 15 Ziche M, Morbidelli L, Choudhuri R. et al. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest 1997; 99: 2625-2634.
• 16 Murohara T, Asahara T, Silver M. et al. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 1998; 101: 2567-2578.
• 17 Boo YC, Hwang J, Sykes M. et al. Shear stress stimulates phosphorylation of eNOS at Ser(635) by a protein kinase A-dependent mechanism. Am J Physiol Heart Circ Physiol 2002; 283: H1819-H1828.
• 18 van Royen N, Hoefer I, Buschmann I. et al. Effects of local MCP-1 protein therapy on the development of the collateral circulation and atherosclerosis in Watanabe hyperlipidemic rabbits. Cardiovasc Res 2003; 57: 178-185.
• 19 Urbich C, Dernbach E, Zeiher AM. et al. Double-edged role of statins in angiogenesis signaling. Circ Res 2002; 90: 737-744.
• 20 Frick M, Dulak J, Cisowski J. et al. Statins differentially regulate vascular endothelial growth factor synthesis in endothelial and vascular smooth muscle cells. Atherosclerosis 2003; 170: 229-236.